[Weekly funding roundup March 21-27] VC inflow continues to remain high
[Weekly funding roundup March 21-27] VC inflow continues to remain high Read More »
Category Added in a WPeMatico Campaign
[Weekly funding roundup March 21-27] VC inflow continues to remain high Read More »
Most marketing platforms promise automation. In practice, what they deliver is a glorified email scheduler with a few if-then rules bolted on. ActiveCampaign is one of the few tools where the automation actually lives up to the branding, and right now you can test the full platform free for 14 days with no credit card […]
This story continues at The Next Web
Andy Shovel and Pete Sharman, who built THIS into a market-leading plant-based food brand, are pivoting hard. Keith is an AI-native regulated law firm targeting conveyancing first, with a 24/7 AI client agent and a target of reducing transaction times by 70%. Launch is Q3 2026. Andy Shovel’s previous company sold plant-based bacon and chicken. […]
This story continues at The Next Web
Keith raises £2M to become the UK’s most automated law firm Read More »
Apple says no one using Lockdown Mode has been hacked with spyware Read More »
Isara, a San Francisco startup that is building software to coordinate thousands of AI agents on complex analytical tasks, has raised $94 million at a $650 million valuation, with OpenAI among the investors. The company was founded nine months ago by two 23-year-olds. It has no product in market. The round was first reported by […]
This story continues at The Next Web
ChatGPT ads are now appearing for roughly one in five questions on the free tier in the US, with an expansion to more countries already planned.
ChatGPT ads are showing up – a lot Read More »
Castfishing is the latest scam, and its scarily like sextortion Read More »
Spain’s largest life sciences VC is moving upstream with InceptionBio, its first fund dedicated to the riskiest stage of biotech: company creation from university and research centre spinouts. CDTI is an anchor LP. The target is at least three new companies in 2026. The hardest part of turning academic science into a biotech company is […]
This story continues at The Next Web
Ysios Capital launches €100M fund to build biotech companies from Spanish science Read More »